Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Suliman Almohtasib"'
Autor:
Mohammad Altermanini, Khaled Ali, Wisam Alwassiti, Suliman Almohtasib, Nabil E. Omar, Abdulaziz Zafar
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 728-733 (2023)
Pembrolizumab is one of the approved treatments for many types of cancer including clear cell renal cell carcinoma (ccRCC). It has improved the prognosis of renal cell carcinoma, yet has many possible immune-related side effects. We discuss a rare ca
Externí odkaz:
https://doaj.org/article/7ec248beb08c448185f96d902c6799eb
